Assembly Concurrent Resolution 17 compiles legislative findings about certified registered nurse anesthetists (CRNAs), commends their clinical and educational contributions, and designates January 19–25, 2025 as National CRNA Week. The text highlights CRNAs’ training, their presence across urban, rural, and military settings, and their use of opioid‑free and opioid‑sparing pain management approaches such as multimodal anesthesia and regional blocks.
The resolution is ceremonial: it makes findings, offers commendation, and instructs the Assembly clerk to distribute copies, but it does not create regulatory authority, appropriate funds, or change scope‑of‑practice law. Its practical value lies in shaping public messaging, supporting professional advocacy, and signaling legislative interest in nonopioid pain‑management strategies.
At a Glance
What It Does
ACR 17 assembles a series of "whereas" findings about CRNAs, formally commends them, and designates the week of January 19–25, 2025 as National Certified Registered Nurse Anesthetists Week. It contains no grant programs, regulatory mandates, or changes to licensing rules; it also instructs the Chief Clerk to transmit copies of the resolution.
Who It Affects
Primary audiences are CRNAs, hospitals and surgical centers, professional associations, and state policymakers who use legislative phrasing for advocacy or public outreach. The resolution imposes no new compliance duties on providers or institutions.
Why It Matters
Although ceremonial, the resolution elevates opioid‑sparing anesthesia techniques in legislative language, which stakeholders can use in marketing, grant applications, workforce recruitment, and policy arguments. It signals legislative acknowledgment of CRNAs’ contributions without providing funding or legal changes.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
ACR 17 is a ceremonial concurrent resolution that collects legislative findings about certified registered nurse anesthetists and uses those findings to commend the profession and set aside a week for recognition. The core of the text is a string of "whereas" clauses that summarize the Legislature’s view of CRNAs’ training, clinical roles, geographic reach, and contributions to pain‑management innovation.
After the findings, the resolution passes two brief "resolved" clauses: one offering commendation and the other directing the Assembly’s Chief Clerk to send copies to the author for distribution.
The bill highlights specific clinical techniques—multimodal anesthesia, peripheral nerve blocks, regional anesthesia, and nonopioid medications—and links CRNA practice to enhanced recovery after surgery (ERAS) protocols. Those passages describe clinical approaches and public‑health benefits (reduced opioid exposure, lower dependence risk), but the resolution does not create clinical standards, require adoption of particular techniques, or allocate training or implementation funding.From an administrative standpoint, ACR 17 carries no fiscal obligation: the Digest flags the Fiscal Committee as "NO." The procedural effect is limited to formal recognition; it neither amends statutes nor instructs any state agency to change policy.
Stakeholders—professional associations, hospitals, and advocacy groups—are the likeliest users of the resolution: they can cite it in outreach, recruitment, and policy briefs to bolster arguments for expanded programs or reimbursement changes, but the resolution alone cannot effect those outcomes.Finally, while the resolution emphasizes opioid‑sparing care, practitioners and payers should note the distinction between legislative recognition and clinical guidance. The text endorses techniques in general terms and celebrates CRNAs’ leadership in education and research, but it leaves open who will fund further training, how insurers will reimburse nonopioid protocols, and whether regulatory agencies will change practice rules in response to the legislative signal.
The Five Things You Need to Know
The resolution designates January 19–25, 2025 as National Certified Registered Nurse Anesthetists Week.
It enumerates opioid‑free and opioid‑sparing techniques—multimodal anesthesia, peripheral nerve blocks, regional anesthesia, and nonopioid medications—as areas where CRNAs contribute to reducing opioid exposure.
ACR 17 is ceremonial: it commends and acknowledges but does not change licensing, scope of practice, or reimbursement rules.
The bill contains a clerical instruction directing the Chief Clerk of the Assembly to transmit copies of the resolution for distribution.
The Digest records no fiscal committee concerns—there is no identified state fiscal impact from the resolution.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings on education, expertise, and practice settings
This cluster of findings emphasizes that CRNAs complete advanced academic and clinical training in pharmacology, physiology, and anesthesia practice and deliver care across diverse settings—urban hospitals, rural facilities, military contexts, and underserved communities. Practically, the findings create a legislative record of professional competence that associations can cite when seeking funding, workforce programs, or public recognition.
Findings on pain‑management approaches and public‑health impact
Several clauses focus on CRNAs’ use of opioid‑free and opioid‑sparing approaches and name specific techniques (multimodal anesthesia, peripheral nerve blocks, regional anesthesia, acetaminophen, NSAIDs, adjunctive therapies). Those enumerations frame such techniques as tools against the opioid epidemic but do not prescribe clinical protocols, set performance benchmarks, or mandate insurer coverage—leaving implementation decisions to clinicians, hospitals, and payers.
Formal commendation and week designation
The first resolved clause formally commends CRNAs for expertise and service and declares the Legislature joins in celebrating National CRNA Week 2025. This is recognition-level action: it confers political and public legitimacy without attaching legal obligations or funding.
Clerical distribution
The second resolved clause directs the Chief Clerk to transmit copies of the resolution to the author for distribution. That instruction is the only operative administrative step in the bill—routine documentation and distribution rather than programmatic follow‑through.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Certified Registered Nurse Anesthetists (CRNAs) — Gain public and legislative recognition that professional associations can use for recruitment, advocacy, and public education about their role and training.
- Hospitals and surgical centers — Can leverage the resolution in public outreach to highlight opioid‑sparing programs and bolster patient confidence in anesthesia services, particularly when promoting ERAS protocols.
- Rural and underserved health facilities — Benefit from legislative attention that affirms the value of CRNAs in settings where anesthesiologists may be scarce, supporting local recruitment and retention efforts.
- Professional associations and educational programs — Receive a legislative citation that can strengthen grant applications, lobbying efforts for reimbursement changes, and outreach to policymakers.
Who Bears the Cost
- Assembly Chief Clerk and legislative staff — Bear a de minimis administrative burden to prepare and transmit copies as directed by the resolution.
- Hospitals and clinicians — May face increased public expectations to expand opioid‑sparing protocols without additional funding or reimbursement, creating operational pressure to adopt practices that require training or resources.
- Insurers and payers — Although not required to change policy, they may receive heightened stakeholder pressure to cover multimodal and nonopioid pain‑management approaches, potentially prompting review of reimbursement practices.
- Advocacy groups — Implicitly tasked with converting recognition into concrete policy or funding, which requires campaign resources and strategy rather than immediate legislative support.
Key Issues
The Core Tension
The central dilemma is between symbolic recognition and substantive change: the resolution elevates CRNAs and opioid‑sparing techniques in the public record—helpful for advocacy—yet it simultaneously avoids committing resources, regulatory adjustments, or clinical safeguards, leaving proponents to decide whether recognition alone advances patient care or merely creates unmet expectations.
ACR 17 is emphatic about the benefits of opioid‑sparing and nonopioid techniques, but the resolution does not address the practical barriers to implementing those approaches at scale. The bill offers no funding for provider training, no directives to insurers on reimbursement, and no statutory changes to credentialing or scope of practice.
That creates a gap: the Legislature signals approval while leaving the hard operational and financial questions unresolved.
There is also a clinical‑policy tension embedded in praising opioid‑free strategies without caveats. For many patients and procedures, opioids remain an appropriate component of pain management; elevating opioid‑sparing language in legislative findings risks being misread as a one‑size‑fits‑all endorsement.
Finally, because the measure is ceremonial, stakeholders seeking regulatory or reimbursement change will need additional legislative or administrative vehicles to convert symbolic recognition into concrete policy outcomes.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.